WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

Fundamentals of Market Access for Pharmaceuticals

Eric Bouteiller Annie Chicoye

$110

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Anthem Press
03 December 2024
This book addresses the global pharmaceutical dilemma through balancing innovation and accessibility and providing a comprehensive toolbox with key concepts and methods for all stakeholders.

Pharmaceuticals are an essential part of health care, and mainly sourced by companies investing in costly R&D and production at their own risks to make them globally available. However, access for patients in need can be restricted due to insufficient medical resources and/or unaffordability. The dilemma between rewarding innovation with prices in line with value and risks for companies and ensuring affordability for patients or health insurances has become critical for all stakeholders, with political and economic implications. The development of universal health coverage puts pressure on governments to control directly or indirectly reimbursement and prices of pharmaceuticals, whereas the flow of innovations addressing infectious, chronic, and life-threatening diseases, thanks to accelerated scientific progress, is growing constantly.

Management of pharmaceutical health care expenditure approach varies according to the historical, cultural, and economic backgrounds that contribute to building each health care system, and companies are confronted with a very complex environment to launch their new drugs and manage their lifecycle until loss of patent. This book explores the different models of health care systems (e.g., Europe, United States, Japan, China) and the criteria and processes for decision making in coverage and pricing of pharmaceuticals. It also provides the analytic tools that are used to inform the decisions, and how market access strategy can be integrated in the product life cycle. Short case studies related to specific disease areas or methods are supporting exposed concepts and methods.

This book targets students, industry or insurance stakeholders, and eventually public decision makers: all will find relevant insights and sources to dig deeper into the topic. The content has been developed partially through a teaching program at CEIBS MBA since 2020.
By:   ,
Imprint:   Anthem Press
Country of Publication:   United Kingdom
Dimensions:   Height: 229mm,  Width: 153mm,  Spine: 21mm
Weight:   454g
ISBN:   9781839992179
ISBN 10:   1839992174
Pages:   292
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Eric Bouteiller is Adjunct Professor at China Europe International Business School (CEIBS) with a focus on pharmaceutical and health care industries. Annie Chicoye is Health Economist, teaching at Sciences Po Paris, School of Public Affairs, on health product industries and at CEIBS in Shanghai with Professor Bouteiller.

Reviews for Fundamentals of Market Access for Pharmaceuticals

“Based on the concept of drug whole life cycle, the authors have established a framework of value assessment, pricing and reimbursement for pharmaceuticals and illustrates how different health systems are facing a variety of challenges and opportunities. The book addresses, governmental and market forces impacting on market access from a global perspective taking into account politics, regulations, culture, ethics, and values. The content of this book has been shaped by three years of teach-ing practice in CEIBS and has been well received. Another feature is a large number of cases in each chapter from the United States, the European Union, and China.” — Shanlian Hu. MD, MSc. Professor of Health Economics, School of Public Health, Fudan University “If health is indeed a ‘supreme good’ that every human being deserves, achieving it involves navigating a complex web of factors, including scientific advancement, public policy, economic limitations, and organization development. These factors vary widely across different regions and over time. The role of pharmaceuticals in promoting health is pivotal. Therefore, the study of pharmaceutical market ac-cess must extend beyond the context of developed nations to include the unique challenges and op-portunities in emerging and developing countries. This book by Eric Boutellier and Annie Chicoye is a timely and valuable resource that will significantly benefit students and professionals in the field.” — Gérard Viens, Emeritus Professor, Health Economics, ESSEC Graduate School


See Also